Stocks
Novo Nordisk (NVO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 46.4% | 43.4% | 49.4% | 50.9% | 50.7% | 55.4% | ||
| Changes by years, y/y, % | 0pp | -3pp | +6pp | +2pp | 0pp | +1.7% | |||
Novo Nordisk. EBITDA margin, %
Novo Nordisk. EBITDA margin, changes, pp
Novo Nordisk (NVO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 59.0% | 56.7% | 44.4% | 50.2% | 71.5% | 55.4% | |
| Changes by years, y/y, % | +2pp | +4pp | -8pp | -3pp | +13pp | |||
| Changes by quarters, q/q, % | +5pp | -2pp | -12pp | +6pp | +21pp | |||
